Low-dose ovulation induction with urinary gonadotropins or recombinant follicle timulating hormone in patients with polycystic ovary syndrome

References

• Adams J, Poison DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355–9
   Google Scholar
• Homburg R. Polycystic ovary syndrome — from gynaecological curiosity to multisystem endo-crinopathy. Hum Reprod 1996;11:29–39
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995;16:322–53
   Google Scholar
• Dunaif A. Insulin resistance in polycystic ovary syndrome. Ann NY Acad Sci 1993;687:60–4
   PubMed Web of Science ®Google Scholar
• Szilágyi A, Rossmanith WG. Polyzystisches Ovar-Syndrom: Zentrale oder periphere Regulations-störung? Zentralbl Gyniikol 1991;113:851–6
   Google Scholar
• Szilágyi A, Hole R, Keckstein J, et al. Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease. Gynecol Endocrinol 1993;7:159–66
   Google Scholar
• Adams J, Franks S, Poison DW, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 1985;2:1375–8
   PubMed Web of Science ®Google Scholar
• Shoham Z, Borenstein R, Lunenfeld B, et al. Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles. Clin Endocrinol 1990;33:271–8
   PubMed Web of Science ®Google Scholar
• Hedon B, Hugues JN, Emperaire JC, et al. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women. Hum Reprod 1998;13:2688–92
   PubMed Web of Science ®Google Scholar
• Gleicher N, Oleske DM, Tur-Kaspa I, etal. Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N EnglJ Med 2000;343:2–7
   Google Scholar
• Daya S, Gunby J. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999;14: 2207–15
   PubMed Web of Science ®Google Scholar
• Shoham Z, Patel A, Jacobs HS. Polycystic ovary syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle stimu-lating hormone. Fertil Steril 1991;55:1051–6
   Google Scholar
• Homburg R, Levy T, Ben-Rafael Z. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for ovulation associated with polycystic ovary syndrome. Fertil Steril 1995;63: 729–33
   Google Scholar
• Balen AH. Hypersecretion of LH: a significants cause of infertility and miscarriage. Br J Obstet Gynaecol 1993;100:1082–9
   PubMedGoogle Scholar
• Recombinant Human FSH Study Group. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular develop-ment before in vitro fertilization. Fertil Steril 1995; 63:77–86
   PubMed Web of Science ®Google Scholar
• Frydman R, Howles CM, Truong F, for The French Multicentre Trialists. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. Hum Reprod 2000;15:520–5
   Google Scholar
• Hamilton-Fairley D, Kiddy D, Watson H, et al. Low dose gonadotrophin therapy for induction of ovulation in 100 women with poly-cystic ovary syndrome. Hum Reprod 1991;6: 1095–9
   Google Scholar
• Serono study 5642, data on file. Geneva, Switzerland: Serono
   Google Scholar
• Coelingh Bennink HJT, Fauser BCJM, Out HJ. Recombinant follicle stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a progressive, multicenter, assessor blind, randomized, clinical trial. Fertil Steril 1998;69:19–25
   Google Scholar
• Bayram N, van Wely M, van der Veen F. Recombinant FSH versus urinary gonadotropins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2002
   Google Scholar
• Hayden CJ, Rutherfold AJ, Balen AH. Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon) . Fertil Steril 1999;71: 106–8
   Google Scholar